Quantitative BioSciences - About the company
Quantitative BioSciences is a funded company based in Solana Beach (United States), founded in 2010 by Jeff Hasty. It operates as a Developer of irrigation water management solutions. Quantitative BioSciences has raised an undisclosed amount in funding. The company has 2313 active competitors, including 507 funded and 339 that have exited. Its top competitors include companies like Antheia, CropX and Transcenta.
Company Details
- Website
- www.qbisci.com/
- Email ID
- *****@qbisci.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2010
Location
Solana Beach, United States
Stage
Funding Raised
Latest Funding Round
Ranked
166th among 2313 active competitors
Employee Count
7 as on Jul 31, 2026
Sign up to download Quantitative BioSciences' company profile
Quantitative BioSciences's funding and investors
Quantitative BioSciences has raised funding over 13 rounds. Its first funding round was on Apr 09, 2018. Its latest funding round was a Grant (prize money) round on Dec 03, 2025 for $*****. 1 investor participated in its latest round. Quantitative BioSciences has 2 institutional investors.
Here is the list of recent funding rounds of Quantitative BioSciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 03, 2025 | 8757872 | Grant (prize money) | 6782070 | 8341991 | 5698640 | 5544557 |
Dec 02, 2025 | 8812092 | Grant (prize money) | 1336582 | 4593482 | 6556019 | |
Apr 01, 2025 | 7213920 | Grant (prize money) | 8435859 | 3500140 | 8589189 |
View details of Quantitative BioSciences's funding rounds and investors
Quantitative BioSciences' founders and board of directors
Founder? Claim ProfileThe founders of Quantitative BioSciences is Jeff Hasty.
Here are the details of Quantitative BioSciences' key team members:
- Jeff Hasty: Founder of Quantitative BioSciences and founder of 1 other company. Contact Info: 1 email address
View details of Quantitative BioSciences's Founder profiles and Board Members
Quantitative BioSciences' employee count trend
Quantitative BioSciences has 7 employees as of Jul 26. Here is Quantitative BioSciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Quantitative BioSciences's Competitors and alternates
Top competitors of Quantitative BioSciences include Antheia, CropX and Transcenta. Here is the list of Top 10 competitors of Quantitative BioSciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
2nd | Provider of digital agronomy platform for precision hardware and software | $51.4M | 66/100 | ||
3rd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
4th | Sadbhav Future Tech 2020, Gurugram (India), Seed | Provider of on-grid and off-grid solar power solutions and pumps | $4.21M | 65/100 | |
5th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
6th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
7th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
8th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
9th | LifeMine Therapeutics 2016, Watertown (United States), Series E | Developer of novel drugs from fungi via genome mining and recombinant overexpression | $563M | 63/100 | |
10th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
166th | Quantitative BioSciences 2010, Solana Beach (United States), Funding Raised | Developer of irrigation water management solutions | - | 45/100 |
Looking for more details on Quantitative BioSciences's competitors? Click here to see the top ones
Quantitative BioSciences's Investments and acquisitions
Quantitative BioSciences has made no investments or acquisitions yet.
Reports related to Quantitative BioSciences
Here is the latest report on Quantitative BioSciences's sector:
News related to Quantitative BioSciences
Media has covered Quantitative BioSciences for 1 event in last 1 year, It was about people movement.
•
•
Are you a Founder ?
FAQs about Quantitative BioSciences
Explore our recently published companies
- Frukt AS - Norway based, Unfunded company
- Ojha Sir Gyanshala - Unfunded company
- Ozeku - Unfunded company
- Mainmeditech - China based, 2020 founded, Unfunded company
- MOBYLIZ - France based, 2020 founded, Unfunded company
- Dave Carmack - Unfunded company